Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: A retrospective review

Background: Sepsis in the neonatal intensive care unit (NICU) remains one of the most significant causes of morbidity and mortality, especially for preterm newborns. Multi-drug resistant organisms (MDROs) are emerging as important pathogens that cause neonatal sepsis in NICU. Therefore, studying the...

Full description

Saved in:
Bibliographic Details
Main Authors: Dawood Yusef (Author), Tala Shalakhti (Author), Samah Awad (Author), Hana'a Algharaibeh (Author), Wasim Khasawneh (Author)
Format: Book
Published: Elsevier, 2018-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b8f46a54eb194b5dbbd01df8660e6427
042 |a dc 
100 1 0 |a Dawood Yusef  |e author 
700 1 0 |a Tala Shalakhti  |e author 
700 1 0 |a Samah Awad  |e author 
700 1 0 |a Hana'a Algharaibeh  |e author 
700 1 0 |a Wasim Khasawneh  |e author 
245 0 0 |a Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: A retrospective review 
260 |b Elsevier,   |c 2018-02-01T00:00:00Z. 
500 |a 1875-9572 
500 |a 10.1016/j.pedneo.2017.06.001 
520 |a Background: Sepsis in the neonatal intensive care unit (NICU) remains one of the most significant causes of morbidity and mortality, especially for preterm newborns. Multi-drug resistant organisms (MDROs) are emerging as important pathogens that cause neonatal sepsis in NICU. Therefore, studying the epidemiology, clinical features, and outcome caused by MDROs vs. non-MDROs, and identifying risk factors that may predispose patients to sepsis by MDROs are important. Methods: Episodes of blood culture-proven sepsis (age: 0-90 days) in the NICU at our institution from January 2012 to December 2015 were retrospectively reviewed. Collected data included demographics, signs at time of sepsis, laboratory values, microbiologic results, and final outcome. We compared clinical and laboratory data and final outcome for patients with sepsis due to MDROs vs. non-MDROs. Multivariate analysis was performed on variables with a P value of <0.05 from univariate analysis. Results: Sixty-eight episodes of sepsis (ages 0-54 days, median 7 days; 34 female; 81% premature) were caused by Gram-negative bacteria (n = 42; 62%), Gram-positive bacteria (n = 21; 31%), or Candida (n = 5; 7%). The most common organisms that were isolated were Acinetobacter baumannii (27%), Klebsiella pneumoniae (22%), coagulase-negative staphylococcus (CoNS) (18%), group B streptococcus (10%), and Escherichia coli (6%). Compared with non-MDROs (n = 16; 31%, excluding CoNS and Candida), MDROs (n = 35; 69%) were associated with higher mortality (P = 0.002) and more delay in providing targeted antimicrobial therapy (P = 0.002) (based on antimicrobial susceptibility tests). Sepsis due to the most resistant organisms (A. baumannii and K. pneumoniae Carbapenemase [KPC]-producing bacteria, n = 20; 39%) was associated with higher mortality (P = 0.001) and significantly associated with exposure to carbapenem and vancomycin before onset of sepsis (cases exposed = 13/20; 65%, P < 0.001). Conclusion: MDROs are the most common cause of sepsis at our NICU and are associated with higher mortality compared with non-MDROs. Previous exposure to carbapenem and vancomycin was associated with sepsis caused by the most resistant organisms. 
546 |a EN 
690 |a multiple antibacterial drug resistance 
690 |a neonatal intensive care unit 
690 |a sepsis 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Pediatrics and Neonatology, Vol 59, Iss 1, Pp 35-41 (2018) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1875957216301577 
787 0 |n https://doaj.org/toc/1875-9572 
856 4 1 |u https://doaj.org/article/b8f46a54eb194b5dbbd01df8660e6427  |z Connect to this object online.